TGF-α inhibits apoptosis of murine gastric pit cells through an NF-κB-dependent pathway

Gastroenterology

Volumn 121, Issue 1, 2001, Pages 56-67

  Kanai, Masashi ^a   Konda, Yoshitaka ^a   Nakajima, Toshio ^a   Izumi, Yoshio ^a   Takeuchi, Toshiyuki ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; STOMACH; STOMACH MUCOSA;

EID: 0034959512     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.25544     Document Type: Article

References (56)

1. Dynamics of epithelial cells in the corpus of the mouse stomach. II. Outward migration of pit cells
2. Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells
3. Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of entero-endocrine and caveolated cells: General conclusions on cell kinetics in the oxyntic epithelium
4. Disruption of epithelial cell-matrix interactions induces apoptosis
5. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium
6. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal
7. Effect of transforming growth factor-alpha on gastric acid secretion in rats and monkeys
8. Increased production of transforming growth factor alpha following acute gastric injury
9. Roles for transforming growth factor-alpha in the stomach
10. Transforming growth factor alpha expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma: An immunohistochemical study
11. Overexpression of TGF alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
12. Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach
13. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor
14. Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells
15. Epidermal growth factor protects epithelial cells against fas-induced apoptosis. Requirement for Akt activation
16. Establishment of gastric surface mucous cell lines from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene
17. Biological characterization of gastric surface mucous cell line GSM06 from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene
18. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes
19. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK
20. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells
21. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway
22. TNF-cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB Science
23. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
24. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
25. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro
26. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
27. The NF-kappa B and I kappa B proteins: New discoveries and insights
28. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
29. Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: Involvement of NF-kappaB activation in drug resistance
30. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane)
31. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
32. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
33. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta
34. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176
35. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42
36. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
37. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
38. The Bcl-2 protein family: Arbiters of cell survival
39. Bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity
40. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
41. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
42. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFKB activation in primary hippocampal neurons
43. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
44. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture
45. EGF receptor signaling inhibits keratinocyte apoptosis: Evidence for mediation by Bcl-XL
46. Activators and effectors of ras p21 proteins
47. Transforming growth factor-alpha: An oncodevelopmental growth factor
48. Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells
49. Inhibition by transforming growth factor (34-43)-alpha, a TGF-alpha antagonist, of gastric carcinogenesis induced by N-methyl-N′-nitro-N- nitrosoguanidine in Wistar rats
50. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
51. Helicobacter pylori infection and the risk for duodenal and gastric ulceration
52. Enhancement by monochloramine of the development of gastric cancers in rats: A possible mechanism of Helicobacter pylori-associated gastric carcinogenesis
53. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori
54. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells
55. Expression and activation of NF-kappa B in the antrum of the human stomach
56. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2